Fatty acid side chain modifications Liraglutide The conjugation of a fatty acid chain to GLP-1 analogs significantly enhances their binding affinity to human serum albumin, thereby generating long-acting peptide formulations with improved pharmacokinetic profiles
It works by mimicking the action of a natural hormone called GLP-1, which helps regulate hunger and food intake
It comes in a prefilled, single-dose pen
Most GLP-1a weight loss and type diabetes medications require a prior authorization (PA) from the insurance provider: FDA-approved weight loss medications: Contrave, Saxenda (liraglutide), Wegovy (semaglutide) Zepbound (tirzepatide) FDA-approved Diabetes medications: Rybelsis, Victoza (liraglutide), Ozempic (semaglutide), or Mounjaro (tirzepatide) If your insurance company says that they cover FDA-approved diabetes medications, it suggests coverage for patients with type 2 diabetes
the combination therapy was significantly associated with a higher percent TBWL in responders and non-responders than GLP-1 analog monotherapy alone